Evidence map›Paper›PMID 41068676›Full record

ArticleBMC cancer2025

Targeting the HIF1A-UCA1-PTBP3 axis: a potential therapeutic strategy for head and neck cancer.

Lydia Chin-Ling Sim, Yi-Zih Kuo, Tsun-Chih Cheng, Chih-Ling Chen, Jenn-Ren Hsiao, Mei-Xuan Ooi, Zixi Yun, Hung-Ying Kao, Sen-Tien Tsai, Li-Wha Wu

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lydia Chin-Ling Sim *Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.
Yi-Zih Kuo *Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.
Tsun-Chih Cheng *Department of Otolaryngology, An Nan Hospital, China Medical University, Tainan, Taiwan, R.O.C.
Chih-Ling ChenInstitute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.
Jenn-Ren HsiaoDepartment of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.
Mei-Xuan OoiInstitute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.
Zixi YunDepartment of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH, U.S.A.
Hung-Ying KaoDepartment of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH, U.S.A.
Sen-Tien TsaiDepartment of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.. T602511@mail.ncku.edu.tw.
Li-Wha WuInstitute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, R.O.C.. liwhawu@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0001-7010-6220

Funding

Changhua Christian Hospital 113-CCH-MST_108National Science and Technology Council 108-2314-B-006-084, 113-2314-B-371-004National Science and Technology Council 111-2314-B-006-039, 113-2320-B-006-017Tainan Municipal An-Nan Hospitall-China Medical University ANHRF112-20
6 · The paper itself

Abstract

backgroundLong non-coding RNAs (lncRNAs) are multifunctional regulators of gene expression and play a vital role in various physiological and pathological processes. The urothelial cancer-associated 1 (UCA1) lncRNA is involved in the development and progression of bladder, colon, stomach, lung, and breast cancers. Pharyngeal cancer, especially those in the hypopharynx (HPC), is a devastating subtype of head and neck cancer often detected in late stages. Although some patients survive under curative treatments, they are still prone to having the disease relapse or metastatic spread. Upregulation of UCA1 expression is associated with disease progression and poor prognosis in HPC patients, but the molecular mechanism by which UCA1 functions in HPC remains unclear.

methodsWe used genetic silencing and ectopic expression approaches to examine the effect of UCA1 dysregulation on the proliferation, colony formation, migration, and invasion of head and neck cancer cells in vitro. Using a xenograft animal model, we employed UCA1-depleted cells to evaluate UCA1’s role in tumor growth and metastasis. RNA pulldown followed by mass spectrometry was used to identify UCA1-interacting proteins. We also examined the downstream effectors and upstream mediator(s) of the UCA1-mediated signaling axis by using RT-qPCR, Western blotting, promoter-driven luciferase, and transendothelial migration assays.

resultsEctopic UCA1 expression increased cell migration and invasion but reduced the proliferation of head and neck cancer cells. The increases in migration and invasion are accompanied by elevated levels of epithelial and mesenchymal markers, reminiscent of incomplete epithelial-mesenchymal transition (EMT). In contrast, depletion of UCA1 had opposite effects. Animal xenograft studies also supported the role of UCA1 in promoting lymph node metastasis. UCA1 was predominantly nuclear localized, where polypyrimidine tract binding protein 3 (PTBP3) binds UCA1 lncRNA. Manipulating PTBP3 expression reversed the effect of UCA1 expression on cell migration and invasion. Moreover, increased UCA1 expression, mimicking the regulatory effect of TGF-β on cyclin D1, p21, and Smad2 phosphorylation, could promote trans-endothelial migration. Significantly, hypoxia induced UCA1 expression partly through an HIF1A-dependent manner.

conclusionsWe conclude that HIF1A-induced nuclear UCA1 stimulated cell migration and invasion via interacting with PTBP3, increasing lymph node metastasis in head and neck cancer.

Indexed as

Head and Neck NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitPolypyrimidine Tract-Binding ProteinRNA, Long NoncodingAnimalsCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMiceSignal TransductionXenograft Model Antitumor AssaysHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitPolypyrimidine Tract-Binding ProteinRNA, Long NoncodingUCA1 RNA, humanHead and neck cancerHypopharyngeal cancerLncRNAPTBP3UCA1

Identifiers

PMID41068676
PMCPMC12512865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.